Contact

Don't Hesitate To Reach Out

First
Last

FAQ

Frequently Asked Questions

Carol Ann Satler, MD, PhD, FACC, FAHA, FAAP is a transformational physician executive, Chief Medical Officer, board member, and innovation and growth advisor across pharma and biotech. She is SVP Clinical Development at Insilico Medicine and also speaks to industry audiences.
She has over 20 years of experience building and leading global teams, guiding drug development from discovery through regulatory approval and commercialization. Her About page lists 20+ years in biopharma clinical development and medical affairs, 300+ professionals led worldwide, and 100+ successful NDA/MAA submissions and global product launches.
Her work spans cardiovascular, respiratory and rare diseases, as well as oncology, immunology and metabolic disorders. She has integrated small molecules, biologics, gene therapy and AI-driven drug design within development programs.
Her three speaking topics are AI-driven drug development from target discovery to first-in-human trials; global clinical development and regulatory strategy; and launch and commercialization excellence for life-changing therapies.
Founders and biotech leaders, clinical teams and medical affairs leads, and investors and board members.
Yes. As a board member she provides strategic guidance and governance to emerging biotech companies, supporting pipeline prioritization, R&D innovation and long-term value creation in areas including gene therapy and fibrosis.
Use the contact form on this page for general enquiries, press and media, partnerships or event bookings, or the booking form on the Speaker page to request a speaking engagement.